COVID-19 vaccination: Centre asks states, UTs to prepare database of healthcare workers for pan-India drive

Health
Typography

Under the plan, the vaccine will be administered to the entire citizens of the country with the frontline healthcare workers top the priority list

The country has reportedly initiated preparation of data bank as part of massive vaccination against COVID-19 and as part of it, the Centre asked all states and Union Territories to collect data of frontline healthcare workers, said a news report.   

The Centre’s move has greater significance at a time when various pharma companies in India have been nearing final stage of the clinical trials of COVID-19 vaccines. The government recently said that the vaccine against coronavirus is expected be available in the country by the end of this year.

As part of the pan-India mega vaccination drive, the Ministry of Health and Family Welfare (MoHFW) in a circular to the health departments of all the states and Union Territories directed to gather information of all the healthcare workers working in all the hospitals including the ones in the private sector, said a report in The New Indian Express.

The Union Health Ministry is preparing a databank of the healthcare providers and other workers in healthcare settings (both government and private), who may be prioritised for receiving the COVID-19 vaccine,” the report said citing the letter from the Centre.

Under the plan, the vaccine will be administered to the entire citizens of the country with the frontline healthcare workers top the priority list.

Various pharma companies in India are conducting clinical trials of vaccines against COVID-19 including Pune-based Serum Institute of India and Hyderabad-based Bharat Biotech.

Union Health Minister Dr Harsh Vardhan recently expressed hope that COVID-19 vaccine would be made available in the country by January next year.

Dr Harsh Vardhan said there are three vaccine candidates in India, out of which one is at the advanced stage of clinical trial of phase-3. Of the other two vaccine candidates, which are in clinical trial of phase-2, one has recently entered the third phase trial, reported DD News.

The health minister said that if the preparations in this regard made so far progress well then 400 to 500 million doses of the COVID-19 vaccine will be available in the country before June and July of next year.

Recently, Bharat Biotech may file for regulatory approval of its COVID-19 vaccine Covaxin by mid of next year, said a news report.

On October 23, the company announced that it received the drug regulator’s nod to initiate the Phase III clinical trials of Covaxin.

Image credit: Manorama

All Comments